anti-CD123 CAR-T treatment
anti-CD123 CAR-T therapy
Phase 1 small_molecule terminated
Quick answer
anti-CD123 CAR-T treatment for Acute Leukemia is a Phase 1 program (small_molecule) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Legend Biotech Corp
- Indication
- Acute Leukemia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated